Soderm plus 0,64 mg/g + 20 mg/g otopina za kožu Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

soderm plus 0,64 mg/g + 20 mg/g otopina za kožu

mibe pharmaceuticals d.o.o., zavrtnica 17, zagreb, hrvatska - betametazondipropionat salicilatna kiselina - otopina za kožu - 0,64 mg/g + 20 mg/g - urbroj: 1 g otopine sadrži 0,64 mg betametazondipropionata (što odgovara 0,5 mg betametazona) i 20 mg salicilatne kiseline

LYSODERM 20 mg/1 g krema Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

lysoderm 20 mg/1 g krema

bosnalijek d.d. - lizozim - krema - 20 mg/1 g - jedan gram kreme sadrži: 20 mg lizozim hidroklorid (što odgovara 800 000 fip jedinica)

Pedmarqsi Europska Unija - hrvatski - EMA (European Medicines Agency)

pedmarqsi

fennec pharmaceuticals (eu) limited - sodium thiosulfate - ear diseases; ototoxicity - svi ostali terapeutski proizvodi - pedmarqsi is indicated for the prevention of ototoxicity induced by cisplatin chemotherapy in patients 1 month to < 18 years of age with localised, non-metastatic, solid tumours.

Sodium Citrate H.I.E.R., 10x /500 ml Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

sodium citrate h.i.e.r., 10x /500 ml

emergo europe molen straat 15 2513 bh the hague nizozemska -

Sodium Iodide (I131) Capsules T kapsula, tvrda Bosna i Hercegovina - hrvatski - Agencija za lijekove i medicinska sredstva Bosne i Hercegovine (Агенција за лијекове и медицинска средства Босне и Херцеговине)

sodium iodide (i131) capsules t kapsula, tvrda

inel d.o.o - natrijum jodid (131 i) - kapsula, tvrda - 1 kapsula tvrda sadrži: rastvor natrijumjodida, radioaktivnosti 37 mbq 7400 mbq na dan kalibracije

Sugammadex Mylan Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex mylan

mylan ireland limited - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by   rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Fresenius Kabi Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex fresenius kabi

fresenius kabi deutschland gmbh - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Amomed Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex amomed

aop orphan pharmaceuticals gmbh - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - uklanjanje neuromuskularne blokade izazvane rokoronom ili vekuronomom. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.

Sugammadex Piramal Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex piramal

piramal critical care b.v. - sugammadex sodium - neuromuskularna blokada - sugammadex - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults.

Sugammadex Adroiq Europska Unija - hrvatski - EMA (European Medicines Agency)

sugammadex adroiq

extrovis eu ltd. - sugammadex sodium - neuromuskularna blokada - svi ostali terapeutski proizvodi - reversal of neuromuscular blockade induced by rocuronium or vecuronium in adults. for the paediatric population: sugammadex is only recommended for routine reversal of rocuronium induced blockade in children and adolescents aged 2 to 17 years.